From Genetic Gold to Regulatory Gaps: Why the DPDPA Needs to Evolve for Effective CRISPR Oversight

Introduction On 25th November 2018, the world woke up to the startling news of designer babies, an event that was termed the ā€œfirst leap of faith in scienceā€. This groundbreaking incident made possible by Clustered Regularly Interspaced Short Palindromic Repeats (ā€œCRISPRā€) – a gene editing technology employed to modify DNA selectively, shocked the world and Continue reading